Stroke Clinical Trial
Official title:
A Multi-site, Interventional, Comparative, Single-arm Trial to Evaluate the Safety and Effectiveness of Keeogo™ Dermoskeleton in Subjects With Hemiparesis Due to Ischemic or Hemorrhagic Stroke.
Verified date | October 2019 |
Source | B-Temia, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A multi-site, interventional, non-comparative, single-arm trial to evaluate the safety of the Keeogo™ Dermoskeleton in subjects with hemiparesis due to ischemic or hemorrhagic stroke.
Status | Enrolling by invitation |
Enrollment | 60 |
Est. completion date | September 2020 |
Est. primary completion date | March 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: To be eligible to participate in this study, an individual must meet all of the following criteria: - Provide signed and dated informed consent form; - Willing to comply with all study procedures and be available for the duration of the study [2-3 days per week, 3-5 consecutive weeks]; - Adults 18 years of age and older; - Confirmed Cerebrovascular Accident (CVA) with hemiparesis; - Stable stroke (= 6 months post-incident) - Sufficient cognition to follow simple instructions and understand the content and purpose of the study (MMSE > 20); - Capable of standing and walking independently for an extended period of time (MMT - 3 hip flexors and extensors, and = 2 knee flexors and extensors with BBS = 45); - Presence of any gait deficit, as defined by one or more of the following clinical observations: - Hip hike - Hip circumduction - Knee spasticity (MAS 2 to 3) as per Modified Ashworth Scale (MAS) - Mid-foot striking (aka 'flat foot landing') - Poor foot clearance (toe/foot drop or foot drag) - Narrow steps (< 1 shoe-width or < 8 cm) - Manual Muscle Test (MMT) of 4/5 for the unaffected upper extremity; - Able to sit on a bench for more than 5 minutes; - Is physically and mentally compatible with device to demonstrate ability to safely activate the Keeogo™ user interface; - Able to understand and follow instructions with assistance if needed. Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation in this study: - Legally blind - Pregnant, lactating, or postpartum sacroiliac joint recovery is ongoing (recent childbirth, not yet cleared for vigorous exercise) - Skin condition that contraindicates use of orthotics or support braces - Recent (<6 mo) lower-body hospitalizations or active treatments due to a joint, muscle, bone, nerve or vascular injury or condition - Scheduled for major surgery within next 4 months - Lower-extremity amputation above or below the knee - Have uncontrolled hypertension - Recent (<1 year) heart attack - Have uncontrolled diabetes - Diagnosed with other health condition(s) that affect mobility and balance; chronic obstructive pulmonary disease; peripheral arterial disease; vestibular disorders; cerebellar disease; cerebral palsy; muscular dystrophy spinal cord injury; other brain injury aside from the reported CVA; |
Country | Name | City | State |
---|---|---|---|
Canada | Assistive Technology Clinic (ATC) | Toronto | Ontario |
United States | James J Peters VA Medical Center - Center for the Medical Consequences of Spinal Cord Injury | Bronx | New York |
United States | Shirley Ryan Ability Lab (SRA) | Chicago | Illinois |
United States | Human Performance and Engineering Research (HPER) | West Orange | New Jersey |
Lead Sponsor | Collaborator |
---|---|
B-Temia, Inc. |
United States, Canada,
Buesing C, Fisch G, O'Donnell M, Shahidi I, Thomas L, Mummidisetty CK, Williams KJ, Takahashi H, Rymer WZ, Jayaraman A. Effects of a wearable exoskeleton stride management assist system (SMA®) on spatiotemporal gait characteristics in individuals after stroke: a randomized controlled trial. J Neuroeng Rehabil. 2015 Aug 20;12:69. doi: 10.1186/s12984-015-0062-0. — View Citation
He Y, Eguren D, Luu TP, Contreras-Vidal JL. Risk management and regulations for lower limb medical exoskeletons: a review. Med Devices (Auckl). 2017 May 9;10:89-107. doi: 10.2147/MDER.S107134. eCollection 2017. Review. — View Citation
Lee SH, Lee HJ, Chang WH, Choi BO, Lee J, Kim J, Ryu GH, Kim YH. Gait performance and foot pressure distribution during wearable robot-assisted gait in elderly adults. J Neuroeng Rehabil. 2017 Nov 28;14(1):123. doi: 10.1186/s12984-017-0333-z. — View Citation
Morawietz C, Moffat F. Effects of locomotor training after incomplete spinal cord injury: a systematic review. Arch Phys Med Rehabil. 2013 Nov;94(11):2297-308. doi: 10.1016/j.apmr.2013.06.023. Epub 2013 Jul 9. Review. — View Citation
Xu J, Murphy SL, Kochanek KD, Bastian B, Arias E. Deaths: Final Data for 2016. Natl Vital Stat Rep. 2018 Jul;67(5):1-76. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | 30-Second Chair Stand Test | Subjects sit in the middle of chair and place hands on opposite shoulder crossed at wrists. Keeping feet flat on floor, back straight, arms against chest, subjects rise to full standing position when told "go" followed by sit down, the start position. This movement is repeated for as many times as possible for 30 seconds. Additionally, the test is repeated for a total of 5 cycles with short rest (= 90 seconds) between sets. Patient and Clinician reported outcomes are assessed for this measure via a sit-to-stand-to-sit question on the survey given for the secondary effectiveness endpoint. |
Duration of study completion for each site, estimated 3-5 weeks | |
Other | Timed Stair Test | Subjects start with both feet on the bottom landing then ascend and descend a set number of stairs as quickly as possible in a safe manner using a rail only if needed. Time is recorded from ascent through descent. Patient and Clinician reported outcomes are assessed for this measure via a stair ascent/descent question on the survey given for the secondary effectiveness endpoint. |
Duration of study completion for each site, estimated 3-5 weeks | |
Other | Patient and Clinician Reported Outcomes (surveys) | Questionnaires provide patient and clinician-centric view of treatment of gait deficit. | Duration of study completion for each site, estimated 3-5 weeks | |
Primary | Incidence of device-related adverse events [Safety] | Safety will be evaluated on the basis of the number of device-related serious adverse events reported for subjects during their participation in the study. | Duration of study participation for each subject, estimated 3-5 weeks | |
Secondary | Incidence of device malfunctions during study procedures [Device Reliability] | Device reliability will be evaluated on the basis of the number of device malfunctions reported by research study staff for the duration of study procedures at each study site. | Duration of study completion for each site, estimated 3-5 weeks | |
Secondary | Incidence of injury to Physical Therapist (PT) caused by device [PT safety] | PT safety will be evaluated on the basis of the number of serious device-related injuries reported by study physical therapists for the duration of study procedures at each study site. | Duration of study completion for each site, estimated 3-5 weeks | |
Secondary | Device, Effectiveness | Clinician and Patient Reported Outcomes (surveys) will be used to assess the effectiveness of the device in assisting gait. The surveys will rate subject performance in walking based on clinician observed deviations and subject perception of mobility limitation due to the stroke. Device effectiveness will be measured based on statistical analysis of the survey data between conditions (baseline compared to device-use) Ratings by the surveys will be validated using instrumented walkway and image data collected during walking. |
Duration of study participation for each subject, estimated 3-5 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Recruiting |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Active, not recruiting |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Completed |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05993221 -
Deconstructing Post Stroke Hemiparesis
|